Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × durvalumab × Clear all

Phase

Status

Completed 9 Active not recruiting 9 Recruiting 6 Withdrawn 4 Unknown 1

Sponsor Class

OTHER 53 OTHER_GOV 2 UNKNOWN 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 14 Paclitaxel 11 Cyclophosphamide 9 Taxes 8 Carboplatin 8 Platinum 6 Gemcitabine 6 1,2-diaminocyclohexaneplatinum II citrate 6 Doxorubicin 5 Cytarabine 5 Brachytherapy 5 fludarabine 4 Trastuzumab 4 Rituximab 4 Radiotherapy, Intensity-Modulated 4 Radiotherapy 4 Oxaliplatin 4 Fluorouracil 4 Docetaxel 4 Capecitabine 4 Watchful Waiting 3 Radiosurgery 3 Pemetrexed 3 Nimorazole 3 Imatinib Mesylate 3 Idarubicin 3 Gene Expression Profiling 3 thymoglobulin 2 regorafenib 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03088059 2023-11-03

UPSTREAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡